October
2004 Archives
October 28, 2004
I Found the Information, But is it
Good Information?
Yesterday I went on a critique-a-thon,
pointing out shortcomings in coverage of less invasive therapies
for CAD on some major health sites. So the question remains
-- what's a patient to do? How can you be sure that a health
site is giving you solid information? And even if it was solid
four years ago, have things changed, making the information
obsolete? How can you find better information? Isn't there
some higher authority that monitors and evaluates this information,
other than me, that is....
Well, there's the HON
(Health on the Net) Seal of Approval. You've seen it.
But what does it mean? HON publishes eight
guidelines that web sites need to follow to receive accreditation.
But a recent report from Consumer
Webwatch stated that only 38% of health sites displaying the HON
code logo actually complied with the HON code.
You can also look at a health
site's "advisory board", which gives you an idea of
the site's status in scheme of things (are these "big-time" names
at important institutions?) For example, the vast majority of
cardiologists on the board of HeartCenterOnline hail from St.
Francis Hospital in Roslyn, Long Island or nearby centers, so
you know "where they're coming from" (i.e. Exit 36
off the Long Island Expressway). It's considered a good hospital,
one of the best on the Island. But how does that impact the information
you're reading?
What I've found true on many of
the encyclopedic patient sites (WebMD, HeartCenterOnline, A.D.A.M.)
is that they are one part health information and two parts business
model. Let's say a good article got written back in 1999 by someone
on the advisory board, or a hired "writer-physician" (my
favorite is WebMD writer Robert Kloner, MD, cardiologist-turned-hospital-thriller-novelist,
see medicalthrillers.com).
In any case, maybe the original article gets "reviewed" in
2003 (usually the date is changed, only the text remains the
same). And these articles get sold ($$$) in bulk packages, syndicated
($$$) to physicians' practice sites, to other health sites, and
the same exact texts are distributed all over the net, unchanged.
Actually, some of the most accurate
and timely information can be found on company sites -- while
the FDA has no control over health sites, it does regulate
medical device manufacturers and pharmaceutical firms -- so their
claims and info have to, by law, be accurate. For example, the
ONLY places I found on the net where drug-eluting stent patients
were given the extremely important information about
continuing antiplatelet therapy for three or more months (other
than our site) were the Johnson & Johnson and Boston
Scientific corporate stent sites.
Finally there are, what we might
call, the fringe sites, or the "quack" sites -- sites
that promote unproven therapies that may just be a waste of money
(chelation therapy is one in particular that has come under scrutiny).
Want to see if a fringe-y site is in any way legit? Run them
through QuackWatch.org.
Although I would caution here -- I can still remember that not
long ago, the term "quack" was thrown at quite a few
doctors in this country who were starting to do this strange
procedure they had learned in Switzerland -- called "coronary
angioplasty".
A good rule of thumb to judging
information is to paraphrase what "Deep Throat" whispered
to Woodward and Bernstein in the parking garage -- "Follow
the Mission". What is the purpose of these site, why
were they started and who founded them -- were they conceived
of as for-profit businesses or as non-profits supported by grants?
What might their agenda be, if it's not you? This whole question
of "dot.com" vs. "dot.org" vs. "dot.gov" and
more is a complex subject and will be the subject of an upcoming
entry.
So if health information on the
net is a mish-mash and each information source has its own particular
agenda, how do you get what seems to be a full picture? Here's
my recommendation. It's a metaphoric suggestion from my co-editor,
who is an excellent chef. When venturing into unknown territory
with a new recipe, she consults several cookbooks and a few online
sources as well. She tries to see where the recipes conjoin and
agree, and where they differ. Her confidence level increases
and she synthesizes a good three-dimensional picture of how all
the ingredients work together (she does the same thing with traveling
-- get several guidebooks and cross-reference them). Likewise,
I would suggest to patients that they take some time, peruse
several sites and see where they agree (make sure to visit ours)
-- you'll have a richer understanding of the particular procedure
or therapy.
October 27, 2004
Medical Misinformation on the Net --
Part Two
Continuing my totally biased survey
of heart info health sites on the Net from yesterday.
American
Heart Association -- Their article on "Stent
Procedure" is brief and pretty accurate, except that
they tell patients blood-thinning drugs, such as ticlopidine
or clopidogrel, should be used for two to four weeks after
the stent procedure. Again, try three to six months! The shorter
period is what used to be recommended for bare metal
stents, but since around 70-90% of stents placed today are
of the drug-eluting type, a minimum of three months, and preferably,
six months to a year is what is considered safe. In fact, there
is great concern in the medical community over the possibility
of blood clotting, even a year after placement. In the words
of Dr. Andrew Ong of Erasmus University, Rotterdam:
“...in patients who have had a drug-eluting
stent, the consequences of stopping antiplatelet therapy at
any time must be weighed carefully.” ("Late
stent thrombosis reported with drug-eluting stents -- Oct 21,
2004 -- theheart.org).
CardiologyChannel --
This multi-page coverage is pretty good. A few additions I would
make: yes, catheterization, angioplasty and stenting are usually
performed from the femoral artery in the groin or, less often,
from the brachial artery in the elbow, but more and more cardiologists
are using the radial
artery in the wrist when possible -- good for patients because
of shortened hospital stay, less complications and not having
to lie flat on a hospital bed for 6-8 hours afterwards. Also,
they mention only the Cypher™ drug-eluting stent, ignoring
Boston Scientific's Taxus™, which was approved in March
2004 (and there will be more...). Oh yeah, throughout the article,
the very important antiplatelet drug Clopidogrel (brand name
= Plavix)
is referred to as "Clopedigrol". Now you know why they
call it "Plavix". And finally, I tested their MDLocator
feature which doctors pay $25 a month to be listed on. I got
no cardiologists in New York or Massachusetts, only 3 practices
in California and 1 in Florida.
Heart1.com --
This site is just one (no pun intended) of the many Body1 health
sites, which include Knee1, Reflux1, Uterus1, Fibroids1, Back1,
Shoulder1 -- you get the idea. Anyway, Heart1.com's article
on Angioplasty is not only very brief, about a dozen lines,
but, well let's say, oddly phrased. It states that the patient "is
placed under local anesthesia" -- did I say odd? --I
think they meant to say that a local anesthetic is injected,
kind of like the dentist does when filling your tooth. Teacher's
next check mark: "a catheter is inserted into a coronary
artery in the groin or, less frequently, the arm" --
maybe this isn't important, but the last time I looked, the coronary
arteries were in the heart. And, "More recently, a stent
has been used in place of a balloon." -- not only have
stents been used for over a decade, but most stents are manufactured
and delivered mounted on balloons, which is how they expand --
additionally, balloons are usually used first to open up the
artery. Finally, the article states that:
"During the procedure, the patient
may feel mild chest pains. The more uncomfortable period
follows...[when]...the patient must lie still for several
hours afterward to allow the puncture site to heal."
True, many patients consider having to lie
still very uncomfortable, but there are a number of physical
sensations that occur during the procedure itself that patients
should be aware of and prepared for (see our article Angioplasty
101). Also -- no mention of vascular closure devices or alternative
approaches (radial) that can minimize the 6-8 hours of immobilization.
Oh well, what should one expect? Their article on the most widely-used
treatment for CAD is shorter than this critique. Oh
yeah, Heart1.com's article states that it was last updated on
May 31, 2004 (Happy Memorial Day!) but the exact
same text appears on the Body1.com site, with a date of January
1, 2000 (Happy New Year!). Really guys, working on holidays??!!??
Heartdisease.About.Com --
The About.com sites are all hosted by a "guide" who
does it for love and a little money -- guides are compensated
by About.com by the number of page views they generate. But the
main draw is that the guides enjoy building a community of readers.
The heart disease site is hosted by a semi-retired EP (electrophysiology)
cardiologist from Pennsylvania, known as DrRich.
He's got a number of articles he's written and links to other
sites, as well as many sponsored links and ads, all part of the
standard About.com package. There's alot of good info on his
site, but I'll only briefly discuss his coverage of the most
current development, drug-eluting stents. When the Cypher ran
into very negative news headlines in Fall of 2003 (e.g. "Deaths
prompt warning on stents") he posted an article. A
month later he posted an follow up "Never Mind!" basically
saying that the FDA took back its concern over the sub-acute
thrombosis problem -- it was no problem! Not
exactly. I would never use the phrase "no problem" when
60 deaths had been reported. I wrote an editorial at
the same time to put the information into perspective, but I'm
just a bit more cautious -- besides, valuable information was
learned from this crisis, namely that physicians needed to be
careful about sizing the stent correctly, and that patients needed
to be in compliance with their post-stent antiplatelet medications.
When Boston Scientific voluntarily recalled
its Taxus stent, DrRich pondered whether the recall was really
the end of the Taxus problems and implied that many cardiologists
were switching to the Cypher. End of coverage. No follow up.
That was four months ago and in the interim, the Taxus has regained
70% of the market and there have been no reports of major problems
with either the Taxus or Cypher.
So how does a patient get accurate and up-to-date
information on the Net? The subject of tomorrow's entry.
October 26, 2004
Medical Misinformation on the Net --
Part One
Something that's been gnawing at
me for quite some time is the state of information, make
that misinformation, about less invasive heart
therapy (angioplasty, stents, etc.) on the net. I've surveyed
most of the major health web sites that heart patients
might go to and have found a number of errors, some glaring,
some nit-picking, some due to just plain mistakes, but
most due to outdated information.
In the past two years this whole field has
undergone nothing less than a revolution, but you wouldn't know
it because most of these web sites are partying like it's 1999.
Mostly, drug-eluting stents get short shrift, which is too bad,
because, as noted cardiologist Gregg
Stone, MD predicts, the volume of open heart bypass surgery
will continue to drop. He thinks that right now over 90% of patients
with coronary artery disease could be managed with drug-eluting
stents.That's like...almost everyone!
So outdated information becomes incorrect and misleading information,
especially if you're a patient considering your options...and
your future. For example:
WebMD --
WebMD is one of the most popular sites on the net. But its main
article on stenting begins: "For
certain people, coronary artery disease can be treated without
surgery." "Certain people" sure sounds like
a "select" group, but even in 2002 that group would
have been over half of all CAD patients -- as
for today, if you listen to Dr. Stone and the interventional
evangelists, 9 out of 10. Outdated=Misleading?
One of the problems with WebMD is that it is
so big that you can navigate to one of several articles on angioplasty
or stents, and each have a slightly different skew, depending
on when they were written or, more appropriately, purchased (more
on this another day). One of their major articles states that:
"Coated stents are being used at some large
medical centers to help prevent restenosis". (Emphasis
mine)
Duh! They are being used everywhere.
Patients are asking for them by name.
Also, WebMD concedes that angioplasty is at
least as effective (and possibly superior) to clot-dissolving
drugs in treating heart attacks. In fact, there are studies saying
that not only is angioplasty superior, but that a person having
a heart attack should go to a hospital that performs emergency
angioplasty, even if it takes up to 2 hours longer. This is a
very important recommendation for patients! (See our feature on
the topic.)
HeartCenterOnline's
Stent Center -- From the health site that recently sent
me an email, sending me to Dr.
Sinatra's Secret Nutrient web site, we get 3 articles,
one on stenting,
one on carotid
artery stenting and one on intravascular
radiotherapy (or intracoronary brachytherapy). This latter
article is quite detailed and states that, while this technique
is still experimental, it:
"...continues to be among the more
promising techniques being studied to prevent the re-closing
of arteries following a catheter-based procedure such as stenting."
This would be news to prominent cardiologist
and TCT organizer Martin Leon, MD, who stated
last month,
"We view vascular brachytherapy as if
you're basically exploding a bomb in the coronary arteries...You
eternally alter the biology of the vessel wall, you affect
endothelialization, you affect platelet absorption...and you
affect the healing response...We have essentially ceased using
vascular brachytherapy [in our hospital]."
So that would be a promising technique?
(note: HeartCenter is not alone -- WebMD also lists brachytherapy
as an important therapy for treating restenosis.)
HeartCenter's stent article is interesting
-- the information is relatively accurate, as far as it goes,
and it does go -- for eight single-spaced detailed printed pages.
Yet only four lines even mention drug-eluting stents, clearly
the most important recent development in all of interventional
cardiology. Patients are informed that they should expect to
take antiplatelet medications for one month (instead of three,
six or more -- mandatory for drug-eluting stent patients), and
there are more references to intracoronary radiation as a new
development. I remember that when HeartCenterOnline first posted
its "Stent Center", it was sponsored by Guidant
Corporation, which at that time was marketing a radiotherapy
device (recently discontinued) and did not -- and still does
not -- manufacture a successful drug-eluting stent of its own.
As for carotid stenting, I will deal with the
whole subject of less invasive therapy outside of the heart at
a later date, but it is an exciting development that crosses
over the medical specialties of vascular surgery, radiology and
cardiology. Okay, I'm just plugging our documentary, Vascular
Pioneers: Evolution of a Specialty.
More sites tomorrow.
October 25, 2004
The Voice in the Ear
Coming back from the TCT
meeting in Washington, I've been reflecting on this whole
field of interventional cardiology and how much it's changed
since I first got involved in it over 25
years ago. As co-editor of Angioplasty.Org,
I write articles and oversee much of the content that appears
on the site, but some of my more personal observations don't
really fit into the structure of a "feature topic",
so I've decided (oh, Lord!) to start a so-called "blog" to
talk about issues in the medical device industry and health
information on the Internet that I feel strongly about.
For better or worse, here it is. I'm calling
it "The Voice in the Ear" -- referencing my many years
as a TV director of live medical demonstration courses, such
as the ones viewed at meetings like the TCT. At the risk of becoming
too "topical" (I'm referring here, of course, to the
so-called controversy about whether George Bush had a wired earpiece
during the 2004 debates) I readily admit that I was, in fact,
the "voice in the ear" for many interventional cardiologists
during the scores of procedures that I broadcast to professional
audiences in the first two decades of coronary angioplasty. Our
mission was to teach other cardiologists how to do procedures.
And when you're in "live broadcast" mode, you must
have a means of communicating with the operating physician. So
the cardiologist had a wireless earpiece, called an IFB (internal
feedback) in his ear, and I could communicate directly (and privately)
with him while he was operating on a patient. Obviously, I used
this power judiciously, but it was usually to convey such important
information as "the next case isn't ready yet, so stretch
your discussion to fill time" or "it's getting late
and the audience needs to go to lunch, so wrap it up" or "can
you tilt the pressure gauge slightly to your right, so the camera
can see how many atmospheres the balloon is being inflated to?"
In any case, I was the voice in the ear to
many of the pioneering interventional cardiologists, so I thought
it would be a fitting title for my ramblings....
|